Prenuvo
Prenuvo provides whole-body MRI screenings for early disease detection. The non-invasive scans are completed without radiation or contrast agents.
Secondary Market Price
How Prenuvo Measures Up
To help you manage your Prenuvo equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Prenuvo's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Prenuvo Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Prenuvo's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Prenuvo is a medical practice that provides proactive health screenings using whole-body magnetic resonance imaging (MRI). The company's service involves a scan of under one hour that uses no contrast agents or radiation, focused on the early detection of cancer and other significant diseases. Headquartered in Redwood City, California, and led by founder and CEO Andrew Lacy, Prenuvo has expanded its operations to include multiple locations across the United States and Canada.
The company's stated goal is to make preventive imaging a part of routine medical care by building clinical evidence and partnering with medical groups and employers. Recent developments include securing $120 million in a Series B funding round. Prenuvo has also established partnerships with companies like Chase, offering rebates to certain cardmembers, and Baker Health, to integrate its MRI scans into a primary care service. Additionally, the company offers discounted scans for active and retired first responders.
- Felicis
- Forerunner Ventures
- Left Lane Capital
- Tony Fadell
- Dr. Timothy A. Springer
- Anne Wojcicki
- Steel Perlot
- Eric Schmidt
- Rande Gerber
- Cindy Crawford
- Co-Founder, Andrew Lacy
- Co-Founder, Dr. Raj Attariwala
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Prenuvo worth joining?
Evaluating whether to join a startup depends on its growth potential, market position, and your personal career goals. A platform like Prospect can help you analyze the financial upside by projecting the value of your potential equity compensation.
What should I do with my Prenuvo stock?
Deciding what to do with private company stock involves weighing factors like your financial goals, tax implications, and the company's outlook. Prospect can help you build a custom strategy for exercising options or selling shares in a tax-optimal way.
Can you sell Prenuvo stock?
As a private company, Prenuvo stock is not publicly traded, but you may be able to sell shares through company-approved tender offers or on secondary markets. Platforms like Prospect offer tools to help you navigate these sales and determine which shares are most tax-efficient to sell.
How can I find the value of my Prenuvo stock?
The value of private stock is typically determined by the company's latest 409A valuation, recent funding rounds, or prices on secondary markets. You can use Prospect’s predictive models, which analyze various data points to forecast the future value of your shares.
What is Prenuvo's equity worth?
A private company's total equity value, or valuation, is usually set during a funding round and is not public information. To understand what your specific holdings might be worth, you can use a platform like Prospect to model different financial scenarios and project your potential post-tax returns.
What is Prenuvo's stock ticker symbol?
Since Prenuvo is a private company, it does not have a stock ticker symbol and is not traded on public stock exchanges. Managing pre-IPO holdings presents unique challenges, which is why Prospect's equity tools exist to help employees optimize their shares.
Can I buy or sell Prenuvo stock?
Selling shares in a private company like Prenuvo is sometimes possible through secondary markets or tender offers, while buying shares is typically restricted to accredited investors. If you are an employee with equity, the Prospect blog offers insights on creating a strategy to maximize your returns.
What is the criteria to buy or invest in Prenuvo stock?
Investing in a private company is generally limited to institutional funds or accredited investors during specific fundraising rounds, and is not open to the general public. For employees who already hold equity, you can learn more about managing and optimizing that investment rather than facilitating new purchases.
